<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We aimed to observe the relationship of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and proarrythmogenic ECG parameters and to evaluate a possible correlation of these parameters to the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> score in patients without overt <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study population consisted of 142 patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and 170 age- and gender-matched control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>In the ECG recordings, resting heart rate, QRS duration, corrected QT duration and corrected QT dispersion were measured </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were classified into three groups based on number of fulfilled <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> criteria: group 1 (three <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> criteria), group 2 (four <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> criteria) and group 3 (five <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> criteria) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> had a higher increased resting heart rate, QTcd, prolonged QRS and QTc duration </plain></SENT>
<SENT sid="5" pm="."><plain>Resting heart rate increases significantly parallel to the increase in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> score across the groups, whilst QRS duration remained unchanged </plain></SENT>
<SENT sid="6" pm="."><plain>QTc duration and QTc dispersion were significantly higher in groups 2 and 3 when compared to group 1 </plain></SENT>
<SENT sid="7" pm="."><plain>However, no significant differences were observed between groups 2 and 3 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: We demonstrated that the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its score related with increased resting heart rate and prolonged repolarization durations in patiens without overt <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>These pro arrhythmogenic parameters could be used in the development of risk stratification schemes for <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>